SURFACE ONCOLOGY, INC. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fef45325-6b38-4996-b8d2-5bd940b11f7b/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-61.9M | 2022-01-01 – 2022-12-31 | evidence 0001718108-23-000004 |
| FY 2021 | $-76.0M | 2021-01-01 – 2021-12-31 | evidence 0001718108-22-000006 |
| FY 2020 | $61.6M | 2020-01-01 – 2020-12-31 | evidence 0001718108-21-000013 |
| FY 2019 | $-57.4M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-009521 |
| FY 2018 | $-9.2M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006783 |
| FY 2017 | $-46.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-006783 |
| FY 2016 | $-18.0M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-006783 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).